Two recurrent pathogenic/likely pathogenic variants in PALB2 account for half of PALB2 positive families in Slovenia by Vita Andreja Mesarič, Ana Blatnik, Kristina Drusany Starič, Ksenija Strojnik, Vida Stegel, Simona Hotujec, Vita Šetrajčič Dragoš, Petra Škerl, Srdjan Novaković, Mateja Krajc

Get full text

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study by Linda A. J. Hendricks, Katja C. J. Verbeek, Janneke H. M. Schuurs-Hoeijmakers, Robin de Putter, Hilde Brems, Sien H. Van Daele, Violetta C. Anastasiadou, Lenka Foretová, Patrick R. Benusiglio, Anna Gerasimenko, Chrystelle Colas, Marie-Charlotte Villy, Claude Houdayer, Maud Branchaud, Robert Hüneburg, Stefan Aretz, Arne Jahn, Verena Steinke-Lange, Giovanni Innella, Daniela Turchetti, Valeria Barili, Maurizio Genuardi, Arianna Panfili, Margherita Baldassarri, Arvīds Irmejs, Mirjam M. de Jong, Thera P. Links, Edward M. Leter, Daniëlle G. M. Bosch, Stephany H. Donze, Rachel S. van der Post, Arjen R. Mensenkamp, Harm Westdorp, Hildegunn Høberg-Vetti, Marianne Tveit Haavind, Kjersti Jørgensen, Lovise Mæhle, Siri Briskemyr, Juliette Dupont Garcia, Ana Blatnik, Judith Balmaña, Maite Torres, Joan Brunet, Roser Lleuger-Pujol, Emma Tham, Marc Tischkowitz, D. Gareth Evans, Zerin Hyder, Nicoline Hoogerbrugge, Janet R. Vos

Get full text